Horizon Pharma to Present at the 12th Annual BIO Investor Forum
(firmenpresse) - DEERFIELD, IL -- (Marketwired) -- 10/02/13 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Todd Smith, executive vice president and chief commercial officer, will present at the 12th Annual BIO Investor Forum on Wednesday, October 9, 2013 at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time) in San Francisco, CA. Mr. Smith will provide an overview of the Company and its corporate activities.
The presentation will be webcast live and may be accessed by visiting Horizon's website at
.
Horizon Pharma, Inc. is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS/LODOTRA, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The Company's strategy is to develop, acquire, in-license and/or co-promote additional innovative medicines where it can execute a targeted commercial approach in specific therapeutic areas while taking advantage of its commercial strengths and the infrastructure the Company has put in place. For more information, please visit .
Robert J. De Vaere
Executive Vice President and Chief Financial Officer
Investors
Kathy Galante
Burns McClellan, Inc.
212-213-0006
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 02.10.2013 - 11:30 Uhr
Sprache: Deutsch
News-ID 302078
Anzahl Zeichen: 0
contact information:
Town:
DEERFIELD, IL
Kategorie:
Equipment & Supplies
Diese Pressemitteilung wurde bisher 225 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Horizon Pharma to Present at the 12th Annual BIO Investor Forum"
steht unter der journalistisch-redaktionellen Verantwortung von
Horizon Pharma (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
